{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:29:16Z","timestamp":1790688556991,"version":"4.1.0"},"reference-count":173,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TropicalMed"],"abstract":"<jats:p>Lassa Fever is a deadly viral haemorrhagic disease, causing annually several hundreds of deaths in West Africa. This zoonotic disease is primarily transmitted to humans by rodents of the genus Mastomys, even though other rodents reportedly carry the Lassa virus, while secondary interhuman transmission accounts for approximately 20% of cases. Although this disease has been endemic in rural zones of Nigeria, Sierra Leone, Liberfia, and Guinea for hundreds of years, it is also characterised by epidemic outbreaks in the dry season, responsible for heavy death tolls. No licensed vaccine or satisfying treatment is currently available. Disease management is hindered by the incomplete knowledge of the epidemiology and distribution of the disease, resulting from an inadequate health and surveillance system. Additional scientific constraints such as the genetic diversity of the virus and the lack of understanding of the mechanisms of immune protection complexify the development of a vaccine. The intricate socio-economic context in the affected regions, and the lack of monetary incentive for drug development, allow the disease to persist in some of West Africa\u2019s poorest communities. The increase in the number of reported cases and in the fatality rate, the expansion of the endemic area, as well as the threat Lassa Fever represents internationally should urge the global community to work on the disease control and prevention. The disease control requires collaborative research for medical countermeasures and tailored public health policies. Lassa Fever, created by the interconnection between animals, humans, and ecosystems, and embedded in an intricate social context, should be addressed with a \u2018One Health\u2019 approach. This article provides an overview of Lassa Fever, focusing on Nigeria, and discusses the perspectives for the control of disease.<\/jats:p>","DOI":"10.3390\/tropicalmed9080178","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T03:46:36Z","timestamp":1723607196000},"page":"178","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Lassa Fever: Critical Review and Prospects for Control"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2170-5128","authenticated-orcid":false,"given":"Marianne E.","family":"Besson","sequence":"first","affiliation":[{"name":"Department of Public Health, Royal Veterinary College, London NW1 0TU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"P\u00e9pin","sequence":"additional","affiliation":[{"name":"Department of Virology and Infectiology, VetAgro Sup Lyon University, 69280 Marcy L\u2019Etoile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Alexandre","family":"Metral","sequence":"additional","affiliation":[{"name":"Department of Geography, Grenoble Alpes University, 38400 Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4269\/ajtmh.1970.19.670","article-title":"Lassa Fever, a New Virus Disease of Man from West Africa","volume":"19","author":"Frame","year":"1970","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.coviro.2019.08.002","article-title":"Lassa fever diagnostics: Past, present, and future","volume":"37","author":"Happi","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.virol.2006.01.026","article-title":"Phylogeny and evolution of old world arenaviruses","volume":"350","author":"Emonet","year":"2006","journal-title":"Virology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/v5010241","article-title":"Arenavirus Variations Due to Host-Specific Adaptation","volume":"5","author":"Zapata","year":"2013","journal-title":"Viruses"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cell.2015.07.020","article-title":"Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus","volume":"162","author":"Andersen","year":"2015","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ibukun, F.I. (2020). Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development. Viruses, 12.","DOI":"10.3390\/v12040386"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ryu, W.S. (2017). Chapter 16\u2014Other Negative-Strand RNA Viruses. Molecular Virology of Human Pathogenic Viruses, Academic Press. Available online: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780128008386000163.","DOI":"10.1016\/B978-0-12-800838-6.00016-3"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1128\/JVI.03349-14","article-title":"The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production","volume":"89","author":"Xing","year":"2015","journal-title":"J. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.antiviral.2013.10.002","article-title":"Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: Hide, mask, hit. Antiviral Res","volume":"100","author":"Zinzula","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.172.5.2861","article-title":"Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells","volume":"172","author":"Baize","year":"2004","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.3390\/v4112766","article-title":"Immune Responses and Lassa Virus Infection","volume":"4","author":"Russier","year":"2012","journal-title":"Viruses"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Schaeffer, J., Carnec, X., Reynard, S., Mateo, M., Picard, C., Pietrosemoli, N., Dillies, M.-A., and Baize, S. (2018). Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007430"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Aloke, C., Obasi, N.A., Aja, P.M., Emelike, C.U., Egwu, C.O., Jeje, O., Edeogu, C.O., Onisuru, O.O., Orji, O.U., and Achilonu, I. (2023). Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives. Viruses, 15.","DOI":"10.3390\/v15010146"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijid.2022.04.004","article-title":"Lassa Virus Infection: A Summary for Clinicians","volume":"119","author":"Raabe","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijid.2019.03.030","article-title":"A cluster of nosocomial Lassa fever cases in a tertiary health facility in Nigeria: Description and lessons learned, 2018","volume":"83","author":"Ipadeola","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref_16","unstructured":"Marrama, E. (2023, October 22). Rapid Risk Assessment: Lassa fever in Nigeria, Benin, Togo, Germany and USA, 24 March 2016. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/rapid-risk-assessment-lassa-fever-nigeria-benin-togo-germany-and-usa-24-march."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00281-017-0637-x","article-title":"Molecular pathogenesis of viral hemorrhagic fever","volume":"39","author":"Basler","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"ref_18","unstructured":"Africa Centres for Disease Control and Prevention (2023, December 10). Lassa Fever. Africa CDC. Available online: https:\/\/africacdc.org\/disease\/lassa-fever\/."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Yaro, C.A., Kogi, E., Opara, K.N., Batiha, G.E.-S., Baty, R.S., Albrakati, A., Altalbawy, F.M.A., Etuh, I.U., and Oni, J.P. (2021). Infection pattern, case fatality rate and spread of Lassa virus in Nigeria. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-05837-x"},{"key":"ref_20","unstructured":"Nigeria Centre for Disease Control (2023, December 28). Lassa Fever Situation Report, Epidemiological Week 46. 24 November\u20131 December 2017; Report No.: 46, Available online: https:\/\/ncdc.gov.ng\/diseases\/sitreps\/?cat=5&name=An%20update%20of%20Lassa%20fever%20outbreak%20in%20Nigeria."},{"key":"ref_21","first-page":"20499361211058252","article-title":"Epidemiological trends of Lassa fever in Nigeria from 2015\u20132021: A review","volume":"8","author":"Grace","year":"2021","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_22","unstructured":"Nigeria Centre for Disease Control (2023, December 28). Lassa Fever Situation Report, Epidemiological Week 52. 24 December\u201331 December 2018; Report No.: 52, Available online: https:\/\/ncdc.gov.ng\/diseases\/sitreps\/?cat=5&name=An%20update%20of%20Lassa%20fever%20outbreak%20in%20Nigeria."},{"key":"ref_23","unstructured":"UK Health Security Agency (UKHSA), Emerging Infections and Zoonoses (EIZ) Team (2023, December 28). Infectious Disease Surveillance and Monitoring for Animal and Human Health: Summary January to June 2023, Available online: https:\/\/www.gov.uk\/government\/publications\/emerging-infections-monthly-summaries\/infectious-disease-surveillance-and-monitoring-for-animal-and-human-health-summary-january-to-june-2023."},{"key":"ref_24","unstructured":"European Centre for Disease Prevention and Control (2020, May 05). Lassa Fever in the Netherlands ex Sierra Leone. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/RRA-Lassa-fever-in-the-Netherlands-ex-Sierra-Leone_0.pdf."},{"key":"ref_25","first-page":"69","article-title":"Epidemiology and control of Lassa fever","volume":"134","author":"McCormick","year":"1987","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","article-title":"Lassa fever: Epidemiology, clinical features, and social consequences","volume":"327","author":"Richmond","year":"2003","journal-title":"BMJ"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijid.2019.07.015","article-title":"Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis","volume":"87","author":"Eberhardt","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/82191","article-title":"The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen","volume":"6","author":"Crotty","year":"2000","journal-title":"Nat. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: Direct molecular test by using ribavirin","volume":"98","author":"Crotty","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","unstructured":"World Health Organisation (2020, October 15). Lassa Fever, Fact Sheets. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lassa-fever."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/bmb\/ldq022","article-title":"Viral haemorrhagic fevers imported into non-endemic countries: Risk assessment and management","volume":"95","author":"Bannister","year":"2010","journal-title":"Br. Med Bull."},{"key":"ref_32","first-page":"e14797","article-title":"Management of Lassa Fever: A Current Update","volume":"13","author":"Alli","year":"2021","journal-title":"Cureus"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2147\/DDDT.S147276","article-title":"Current research for a vaccine against Lassa hemorrhagic fever virus","volume":"12","author":"Warner","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21010\/Ajidv16i2S.6","article-title":"Prospects of Lassa fever candidate vaccines","volume":"16","author":"Isaac","year":"2022","journal-title":"Afr. J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.185.4147.263","article-title":"Lassa Virus Isolation from Mastomys natalensis Rodents during an Epidemic in Sierra Leone","volume":"185","author":"Monath","year":"1974","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s13071-018-2991-5","article-title":"Widespread arenavirus occurrence and seroprevalence in small mammals, Nigeria","volume":"11","author":"Olayemi","year":"2018","journal-title":"Parasites Vectors"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Oloniniyi, O.K., Unigwe, U.S., Okada, S., Kimura, M., Koyano, S., Miyazaki, Y., Iroezindu, M.O., Ajayi, N.A., Chukwubike, C.M., and Chika-Igwenyi, N.M. (2018). Genetic characterization of Lassa virus strains isolated from 2012 to 2016 in southeastern Nigeria. PLoS Neglected Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006971"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aau9343","article-title":"Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak","volume":"363","author":"Kafetzopoulou","year":"2019","journal-title":"Science"},{"key":"ref_39","unstructured":"World Health Organisation (2023, December 10). Lassa Fever\u2014Nigeria. WHO Disease Outbreak News. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON463."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10393-016-1098-8","article-title":"Rat-atouille: A Mixed Method Study to Characterize Rodent Hunting and Consumption in the Context of Lassa Fever","volume":"13","author":"Bonwitt","year":"2016","journal-title":"Ecohealth"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4269\/ajtmh.1996.55.661","article-title":"Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea","volume":"55","author":"Lukashevich","year":"1996","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e0009212","DOI":"10.1371\/journal.pntd.0009212","article-title":"Hunting and consumption of rodents by children in the Lassa fever endemic area of Faranah, Guinea. PLoS Negl","volume":"15","author":"Douno","year":"2021","journal-title":"Trop Dis."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Terashima, H., and Hewlett, B.S. (2016). Social Learning and Innovation in Contemporary Hunter-Gatherers: Evolutionary and Ethnographic Perspectives, Springer.","DOI":"10.1007\/978-4-431-55997-9"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kern\u00e9is, S., Koivogui, L., Magassouba, N., Koulemou, K., Lewis, R., Aplogan, A., Grais, R.F., Guerin, P.J., and Fichet-Calvet, E. (2009). Prevalence and Risk Factors of Lassa Seropositivity in Inhabitants of the Forest Region of Guinea: A Cross-Sectional Study. PLoS Negl. Trop Dis., 3.","DOI":"10.1371\/journal.pntd.0000548"},{"key":"ref_45","unstructured":"Pfau, C.J. (2020, April 11). Arenaviruses, Medical Microbiology, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK8193\/."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/2010105820932616","article-title":"Need for preventive and control measures for Lassa fever through the One Health strategic approach","volume":"29","author":"Abdullahi","year":"2020","journal-title":"Proc. Singap. Health"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Cadmus, S., Taiwo, O.J., Akinseye, V., Cadmus, E., Famokun, G., Fagbemi, S., Ansumana, R., Omoluabi, A., Ayinmode, A., and Oluwayelu, D. (2023). Ecological correlates and predictors of Lassa fever incidence in Ondo State, Nigeria 2017\u20132021: An emerging urban trend. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-47820-3"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Dalhat, M.M., Olayinka, A., Meremikwu, M.M., Dan-Nwafor, C., Iniobong, A., Ntoimo, L.F., Onoh, I., Mba, S., Ohonsi, C., and Arinze, C. (2022). Epidemiological trends of Lassa fever in Nigeria, 2018\u20132021. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0279467"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4269\/ajtmh.2007.77.169","article-title":"Poor Housing Quality Increases Risk of Rodent Infestation and Lassa Fever in Refugee Camps of Sierra Leone","volume":"77","author":"Bonner","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/JS9.0000000000000178","article-title":"An update on current understanding of the epidemiology and management of the re-emerging endemic Lassa fever outbreaks","volume":"109","author":"Malik","year":"2023","journal-title":"Int. J. Surg. Lond. Engl."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"McKendrick, J.Q., Tennant, W.S.D., and Tildesley, M.J. (2023). Modelling seasonality of Lassa fever incidences and vector dynamics in Nigeria. PLoS Negl Trop Dis., 17.","DOI":"10.1101\/2023.07.25.23293135"},{"key":"ref_52","unstructured":"Nigeria Centre for Disease Control (2024, August 09). Lassa Fever Situation Report, Epidemiological Week 29. 17 July\u201323 July 2023; Report No.: 29, Available online: https:\/\/ncdc.gov.ng\/diseases\/sitreps\/?cat=5&name=An%20update%20of%20Lassa%20fever%20outbreak%20in%20Nigeria."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/bmj.311.7009.857","article-title":"Review of cases of nosocomial Lassa fever in Nigeria: The high price of poor medical practice","volume":"311","author":"Tomori","year":"1995","journal-title":"BMJ"},{"key":"ref_54","unstructured":"Child, M.F., Roxburgh, L., and Do Linh San, E. (2016). A conservation assessment of Mastomys spp.. The Red List of Mammals of South Africa, Swaziland and Lesotho, South African National Biodiversity Institute and Endangered Wildlife Trust."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"VII","DOI":"10.1016\/j.coviro.2019.09.001","article-title":"Editorial overview: Lassa virus","volume":"37","author":"Schmaljohn","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/inthealth\/ihac076","article-title":"Lassa fever cases suffer from severe underreporting based on reported fatalities","volume":"15","author":"Simons","year":"2022","journal-title":"Int. Health"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Shaffer, J.G., Grant, D.S., Schieffelin, J.S., Boisen, M.L., Goba, A., Hartnett, J.N., Levy, D.C., Yenni, R.E., Moses, L.M., and Fullah, M. (2014). Lassa Fever in Post-Conflict Sierra Leone. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002748"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.297.6648.584","article-title":"A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy","volume":"297","author":"Price","year":"1988","journal-title":"BMJ"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.1990.03450160063030","article-title":"Acute Sensorineural Deafness in Lassa Fever","volume":"264","author":"Cummins","year":"1990","journal-title":"J. Am. Med. Assoc."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/019459989210600303","article-title":"Audiometric comparison of Lassa fever hearing loss and idiopathic sudden hearing loss: Evidence for viral cause","volume":"106","author":"Liao","year":"1992","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Mateer, E.J., Huang, C., Shehu, N.Y., and Paessler, S. (2018). Lassa fever-induced sensorineural hearing loss: A neglected public health and social burden. PLoS Negl. Trop Dis., 12.","DOI":"10.1371\/journal.pntd.0006187"},{"key":"ref_62","unstructured":"McPherson, B., and Brouillette, R. (2008). Audiology in Developing Countries, Nova Science Publishers, Inc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3201\/eid1205.050052","article-title":"Historical Lassa Fever Reports and 30-year Clinical Update","volume":"12","author":"Macher","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.3201\/eid2612.200084","article-title":"One-Year Retrospective Review of Psychiatric Consultations in Lassa Fever, Southern Nigeria","volume":"26","author":"Okogbenin","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_65","first-page":"577","article-title":"Lassa fever: Review of epidemiology and epizootiology","volume":"52","author":"Monath","year":"1975","journal-title":"Bull. World Health Organ."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Manning, J.T., Forrester, N., and Paessler, S. (2015). Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.01037"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Lalis, A., Leblois, R., Lecompte, E., Denys, C., ter Meulen, J., and Wirth, T. (2012). The Impact of Human Conflict on the Genetics of Mastomys natalensis and Lassa Virus in West Africa. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037068"},{"key":"ref_68","unstructured":"Nigeria Centre for Disease Control (2023, December 10). Lassa Fever Situation Report, Epidemiological Week 52. 27 December 2020\u20132 January 2021; Report No.: 52, Available online: https:\/\/ncdc.gov.ng\/diseases\/sitreps\/?cat=5&name=An%20update%20of%20Lassa%20fever%20outbreak%20in%20Nigeria."},{"key":"ref_69","unstructured":"Nigeria Centre for Disease Control (2024, May 10). Lassa Fever Situation Report, Epidemiological Week 52; Report No.: 52, Available online: https:\/\/ncdc.gov.ng\/diseases\/sitreps\/?cat=5&name=An%20update%20of%20Lassa%20fever%20outbreak%20in%20Nigeria."},{"key":"ref_70","unstructured":"Africa Centres for Disease Control and Prevention (2024, July 21). Africa CDC Weekly Event Based Surveillance Report, June 2024. Available online: https:\/\/africacdc.org\/download\/africa-cdc-weekly-event-based-surveillance-report-june-2024\/."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3201\/eid2403.171905","article-title":"New Lineage of Lassa Virus, Togo, 2016","volume":"24","author":"Whitmer","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcv.2006.08.015","article-title":"Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa","volume":"37","author":"Emmerich","year":"2006","journal-title":"J. Clin. Virol."},{"key":"ref_73","first-page":"166","article-title":"The First Cases of Lassa Fever in Ghana","volume":"46","author":"Dzotsi","year":"2012","journal-title":"Ghana Med. J."},{"key":"ref_74","unstructured":"Centres for Disease Control and Prevention (2024, August 09). Outbreak Distribution Map|Lassa Fever|CDC, Available online: https:\/\/www.cdc.gov\/lassa-fever\/about\/index.html."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"19145","DOI":"10.2807\/ese.14.10.19145-en","article-title":"The first case of Lassa fever imported from Mali to the United Kingdom, February 2009","volume":"14","author":"Atkin","year":"2009","journal-title":"Eurosurveillance"},{"key":"ref_76","unstructured":"World Health Organisation Regional Office for Africa (2023, December 23). Weekly Bulletin on Outbreak and other Emergencies: Week 47: 18\u201324 November 2019. Available online: https:\/\/iris.who.int\/handle\/10665\/329974."},{"key":"ref_77","unstructured":"Africa Centres for Disease Control and Prevention (2024, August 09). Africa CDC Weekly Event Based Surveillance Report, 17 February 2024. Available online: https:\/\/africacdc.org\/download\/africa-cdc-weekly-event-based-surveillance-report-february-2023\/."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/trstmh\/trv047","article-title":"Mapping the zoonotic niche of Lassa fever in Africa","volume":"109","author":"Mylne","year":"2015","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/bij.12013","article-title":"A mitochondrial phylogeographic scenario for the most widespread African rodent, Mastomys natalensis","volume":"108","author":"Colangelo","year":"2013","journal-title":"Biol. J. Linn. Soc."},{"key":"ref_80","unstructured":"Granjon, L. (2024, May 12). Mastomys natalensis. IUCN Red List Threat Species. Available online: https:\/\/www.iucnredlist.org\/species\/12868\/115107375."},{"key":"ref_81","unstructured":"Redding, D.W., Moses, L.M., Cunningham, A.A., Wood, J., and Jones, K.E. (2020, April 17). Environmental-Mechanistic Modelling of the Impact of Global Change on Human Zoonotic 2 Disease Emergence: A Case Study of Lassa Fever. Macro-Mechanistic Modelling of Zoonotic Disease Emergence. Available online: https:\/\/www.repository.cam.ac.uk\/handle\/1810\/256060."},{"key":"ref_82","first-page":"276","article-title":"Understanding the cryptic nature of Lassa fever in West Africa","volume":"111","author":"Gibb","year":"2017","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Happi, A.N., Olumade, T.J., Ogunsanya, O.A., Sijuwola, A.E., Ogunleye, S.C., Oguzie, J.U., Nwofoke, C., Ugwu, C.A., Okoro, S.J., and Otuh, P.I. (2022). Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.00366-22"},{"key":"ref_84","first-page":"286","article-title":"Impacts of Deforestation on the Spread of Mastomys natalensis in Nigeria","volume":"11","author":"Adetola","year":"2019","journal-title":"World Sci. News"},{"key":"ref_85","first-page":"609","article-title":"Recent isolations of Lassa virus from Nigerian rodents","volume":"52","author":"Wulff","year":"1975","journal-title":"Bull. World Health Organ."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/15303660160025912","article-title":"Lassa Fever in Guinea: II. Distribution and Prevalence of Lassa Virus Infection in Small Mammals","volume":"1","author":"Demby","year":"2001","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/vbz.2013.1484","article-title":"Lassa Serology in Natural Populations of Rodents and Horizontal Transmission","volume":"14","author":"Koivogui","year":"2014","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Gryseels, S., Baird, S.J.E., Borremans, B., Makundi, R., Leirs, H., and de Bellocq, J.G. (2017). When Viruses Don\u2019t Go Viral: The Importance of Host Phylogeographic Structure in the Spatial Spread of Arenaviruses. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006073"},{"key":"ref_89","unstructured":"Grandcolas, P., and Maurel, M.C. (2018). 11\u2014Mice and Men: An Evolutionary History of Lassa Fever. Biodiversity and Evolution, Elsevier. Available online: http:\/\/www.sciencedirect.com\/science\/article\/pii\/B9781785482779500115."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1038\/s41467-022-33112-3","article-title":"Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades","volume":"13","author":"Klitting","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2294859","DOI":"10.1080\/22221751.2023.2294859","article-title":"Lassa virus in novel hosts: Insights into the epidemiology of lassa virus infections in southern Nigeria","volume":"13","author":"Happi","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Arruda, L.B., Free, H.B., Simons, D., Ansumana, R., Elton, L., Haider, N., Honeyborne, I., Asogun, D., McHugh, T.D., and Ntoumi, F. (2023). Current sampling and sequencing biases of Lassa mammarenavirus limit inference from phylogeography and molecular epidemiology in Lassa fever endemic regions. PLoS Glob. Public Health, 3.","DOI":"10.1101\/2023.06.20.23291686"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virol.2023.01.006","article-title":"Genetic basis underlying Lassa fever endemics in the Mano River region, West Africa","volume":"579","author":"Li","year":"2023","journal-title":"Virology"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Olayemi, A., Cadar, D., Magassouba, N., Obadare, A., Kourouma, F., Oyeyiola, A., Fasogbon, S., Igbokwe, J., Rieger, T., and Bockholt, S. (2016). New Hosts of The Lassa Virus. Sci. Rep., 6.","DOI":"10.1038\/srep25280"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e00929-19","DOI":"10.1128\/JVI.00929-19","article-title":"Phylogeography of Lassa Virus in Nigeria","volume":"93","author":"Ehichioya","year":"2019","journal-title":"J. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0140-6736(87)90767-7","article-title":"Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever","volume":"330","author":"Clegg","year":"1987","journal-title":"Lancet"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-018-0049-5","article-title":"Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development","volume":"3","author":"Hallam","year":"2018","journal-title":"NPJ Vaccines"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Akokuwebe, M.E., and Idemudia, E.S. (2022). A Comparative Cross-Sectional Study of the Prevalence and Determinants of Health Insurance Coverage in Nigeria and South Africa: A Multi-Country Analysis of Demographic Health Surveys. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19031766"},{"key":"ref_99","unstructured":"Sasu (2023, December 24). Nigeria: Health Insurance Coverage, by Area and Gender|Statista. Available online: https:\/\/www.statista.com\/statistics\/1124757\/health-insurance-coverage-in-nigeria-by-area-and-gender\/."},{"key":"ref_100","unstructured":"World Bank (2023, December 24). Nigeria Overview: Development News, Research, Data. Available online: https:\/\/www.worldbank.org\/en\/country\/nigeria\/overview."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4103\/0300-1652.170382","article-title":"Operationalizing universal health coverage in Nigeria through social health insurance","volume":"56","author":"Okpani","year":"2015","journal-title":"Niger. Med J."},{"key":"ref_102","unstructured":"Eke, C. (2023, December 24). Nigeria\u2014Healthcare. Official Website of the USA International Trade Association, Available online: https:\/\/www.trade.gov\/country-commercial-guides\/nigeria-healthcare."},{"key":"ref_103","unstructured":"United Nations Development Programme (2023, December 27). HDR21-22_Statistical_Annex_HDI_Table.xlsx. Available online: https:\/\/view.officeapps.live.com\/op\/view.aspx?src=https%3A%2F%2Fhdr.undp.org%2Fsites%2Fdefault%2Ffiles%2F2021-22_HDR%2FHDR21-22_Statistical_Annex_HDI_Table.xlsx&wdOrigin=BROWSELINK."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/heapol\/czz070","article-title":"Corruption in Anglophone West Africa health systems: A systematic review of its different variants and the factors that sustain them","volume":"34","author":"Onwujekwe","year":"2019","journal-title":"Heal. Policy Plan."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10389-022-01814-z","article-title":"Mistrust of the Nigerian health system and its practical implications: Qualitative insights from professionals and non-professionals in the Nigerian health system","volume":"32","author":"Ogueji","year":"2024","journal-title":"J. Public Health"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4081\/jphia.2018.882","article-title":"Mass media awareness campaign and the prevention of the spread of Lassa fever in the rural communities of Ebonyi State, Nigeria: Impact evaluation","volume":"9","author":"Wogu","year":"2018","journal-title":"J. Public Health Afr."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.socscimed.2017.12.028","article-title":"Unintended consequences of the \u2018bushmeat ban\u2019 in West Africa during the 2013\u20132016 Ebola virus disease epidemic","volume":"200","author":"Bonwitt","year":"2018","journal-title":"Soc. Sci. Med."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Woyessa, A.B., Maximore, L., Keller, D., Dogba, J., Pajibo, M., Johnson, K., Saydee, E., Monday, J., Tuopileyi, R., and Mahmoud, N. (2019). Lesson learned from the investigation and response of Lassa fever outbreak, Margibi County, Liberia, 2018: Case report. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4257-z"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1309\/AJCPQ5KTKAGSSCFN","article-title":"Medical Laboratories in Sub-Saharan Africa That Meet International Quality Standards","volume":"141","author":"Schroeder","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Boisen, M.L., Uyigue, E., Aiyepada, J., Siddle, K.J., Oestereich, L., Nelson, D.K.S., Bush, D.J., Rowland, M.M., Heinrich, M.L., and Eromon, P. (2020). Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-65736-0"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e001116","DOI":"10.1136\/bmjgh-2018-001116","article-title":"Diagnostics for Lassa fever virus: A genetically diverse pathogen found in low-resource settings","volume":"4","author":"Mazzola","year":"2019","journal-title":"BMJ Glob. Health"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Akpede, G.O., Asogun, D.A., Okogbenin, S.A., Dawodu, S.O., Momoh, M.O., Dongo, A.E., Ike, C., Tobin, E., Akpede, N., and Ogbaini-Emovon, E. (2019). Caseload and Case Fatality of Lassa Fever in Nigeria, 2001\u20132018: A Specialist Center\u2019s Experience and Its Implications. Front. Public Health, 7.","DOI":"10.3389\/fpubh.2019.00251"},{"key":"ref_113","first-page":"56","article-title":"Knowledge of Lassa fever and use of infection prevention and control facilities among health care workers during Lassa fever outbreak in Ondo State, Nigeria","volume":"30","author":"Ijarotimi","year":"2018","journal-title":"Pan. Afr. Med. J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1515\/MAMM.2008.023","article-title":"Correlating small mammal community characteristics and habitat integrity in the Caledon Nature Reserve, South Africa","volume":"72","author":"Avenant","year":"2008","journal-title":"Mammalia"},{"key":"ref_115","first-page":"138","article-title":"The Influence of Fire on Rodent Abundance at the N\u2019washitshumbe Enclosure Site, Kruger National Park, South Africa","volume":"47","author":"MacFadyen","year":"2012","journal-title":"Afr. Zool."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.20-0487","article-title":"Lassa Fever: An Evolving Emergency in West Africa","volume":"104","author":"Balogun","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"taaa035","DOI":"10.1093\/jtm\/taaa035","article-title":"Fifty years of imported Lassa fever: A systematic review of primary and secondary cases","volume":"27","author":"Wolf","year":"2020","journal-title":"J. Travel Med."},{"key":"ref_118","unstructured":"World Health Organisation (2023, December 27). Lassa Fever\u2014United Kingdom of Great Britain and Northern Ireland. Disease Outbreak News. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/lassa-fever-united-kingdom-of-great-britain-and-northern-ireland."},{"key":"ref_119","first-page":"165","article-title":"Lassa Fever Natural History and Clinical Management","volume":"440","author":"Grant","year":"2023","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40696-016-0018-3","article-title":"Lassa fever: Another threat from West Africa","volume":"2","year":"2016","journal-title":"Disaster Mil. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4269\/ajtmh.18-0753","article-title":"Potential for Seasonal Lassa Fever Case Exportation from Nigeria","volume":"100","author":"Tuite","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_122","unstructured":"World Health Organisation (2023, December 28). Lassa Fever\u2014Germany. Disease Outbreak News. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/23-march-2016-lassa-fever-germany-en."},{"key":"ref_123","unstructured":"World Health Organisation (2023, December 28). Lassa Fever\u2014Togo. Disease Outbreak News. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/23-march-2016-lassa-fever-togo-en."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijid.2022.02.020","article-title":"A challenging response to a Lassa fever outbreak in a non endemic area of Sierra Leone in 2019 with export of cases to The Netherlands","volume":"117","author":"Njuguna","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_125","unstructured":"Ihekweazu, C. (2023, December 28). National Guidelines for Lassa Fever Case Management, Available online: https:\/\/ncdc.gov.ng\/themes\/common\/docs\/protocols\/92_1547068532.pdf."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"Mehand","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_127","unstructured":"World Health Organisation (2020, June 11). Prioritizing Diseases for Research and Development in Emergency Contexts. Available online: https:\/\/www.who.int\/activities\/prioritizing-diseases-for-research-and-development-in-emergency-contexts."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00103-019-03061-2","article-title":"Developing vaccines against epidemic-prone emerging infectious diseases","volume":"63","author":"Bernasconi","year":"2020","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"ref_129","unstructured":"CEPI (2024, July 21). Testing the Tests: Scientists Seek Out Best on-the-Spot Diagnostics for Deadly Nipah and Lassa. CEPI Official Website. Available online: https:\/\/cepi.net\/\/testing-tests-scientists-seek-out-best-spot-diagnostics-deadly-nipah-and-lassa."},{"key":"ref_130","unstructured":"Epidemic Preparedness Innovations (2024, July 21). Enable Epi Study\u2014Epidemic Preparedness Innovations. The Global Health Network. Available online: https:\/\/epi.tghn.org\/epidemiology\/epi-studies\/."},{"key":"ref_131","unstructured":"Goios, A., Varma, A., Kagia, C., Otiende, M., and Suykerbuyk, P. (2022). Enable Lassa Research Programme Mid-Term Workshop, The Global Health Network."},{"key":"ref_132","unstructured":"The West Africa Lassa Fever Consortium (2024, August 09). A Clinical Development Strategy to Deliver New Lassa Fever Therapeutics. Available online: https:\/\/isaricdev.wpenginepowered.com\/wp-content\/uploads\/2023\/03\/A-Clinical-Development-Strategy-to-Deliver-New-Lassa-Fever-Therapeutics.pdf."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1017\/S1744133112000321","article-title":"Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research?","volume":"8","year":"2013","journal-title":"Health Econ. Policy Law"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41579-022-00789-8","article-title":"Lassa fever\u2014The road ahead","volume":"21","author":"Garry","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_135","first-page":"111","article-title":"Lassa Virus Countermeasures","volume":"440","author":"Melnik","year":"2023","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/infdis\/jiv522","article-title":"Efficacy of Favipiravir Alone and in Combination with Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever","volume":"213","author":"Oestereich","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3201\/eid2409.180233","article-title":"Use of Favipiravir to Treat Lassa Virus Infection in Macaques","volume":"24","author":"Rosenke","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/cid\/cix406","article-title":"Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever","volume":"65","author":"Raabe","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Cashman, K.A., Wilkinson, E.R., Posakony, J., Madu, I.G., Tarcha, E.J., Lustig, K.H., Korth, M.J., Bedard, K.M., and Amberg, S.M. (2022). Lassa antiviral LHF-535 protects guinea pigs from lethal challenge. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-23760-2"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e0095122","DOI":"10.1128\/aac.00951-22","article-title":"Safety and Pharmacokinetics of LHF-535, a Potential Treatment for Lassa Fever, in Healthy Adults","volume":"66","author":"Amberg","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/095632020601700402","article-title":"Combinatorial Ribavirin and Interferon Alfacon-1 Therapy of Acute Arenaviral Disease in Hamsters","volume":"17","author":"Gowen","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1128\/JVI.01948-08","article-title":"Early and Strong Immune Responses Are Associated with Control of Viral Replication and Recovery in Lassa Virus-Infected Cynomolgus Monkeys","volume":"83","author":"Baize","year":"2009","journal-title":"J. Virol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e2304876120","DOI":"10.1073\/pnas.2304876120","article-title":"A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus","volume":"120","author":"Cross","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"101392","DOI":"10.1016\/j.xcrm.2024.101392","article-title":"Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus","volume":"5","author":"Cross","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref_146","unstructured":"ALIMA (2024, July 21). First-Ever Global Alliance of Researchers, Health Workers, and Humanitarians Join Forces to Fight the Deadly Lassa Fever Virus. ALIMA\u2014The Alliance for Medical Action. Available online: https:\/\/alima.ngo\/en\/press-releases\/lassa-fever-alliance-virus\/."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/tmi.13876","article-title":"Lassa fever vaccine candidates: A scoping review of vaccine clinical trials","volume":"28","author":"Sulis","year":"2023","journal-title":"Trop. Med. Int. Health"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Moore, K.A., Ostrowsky, J.T., Mehr, A.J., Johnson, A.R., Ulrich, A.K., Moua, N.M., Fay, P.C., Hart, P.J., Golding, J.P., and Benassi, V. (2024). Lassa fever research priorities: Towards effective medical countermeasures by the end of the decade. Lancet Infect. Dis., ahead of print.","DOI":"10.1016\/S1473-3099(24)00229-9"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"eaaw3163","DOI":"10.1126\/scitranslmed.aaw3163","article-title":"Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot","volume":"11","author":"Mateo","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/s41467-023-37050-6","article-title":"Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys","volume":"14","author":"Mateo","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(23)00048-X","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: A randomised, placebo-controlled, first-in-human trial","volume":"401","author":"Tschismarov","year":"2023","journal-title":"Lancet"},{"key":"ref_152","unstructured":"ClinicalTrials (2024, July 21). No Study Results Posted|Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers. ClinicalTrials.gov (US Government), Available online: https:\/\/clinicaltrials.gov\/study\/NCT03805984?tab=results."},{"key":"ref_153","unstructured":"Marrero, I. (2024, August 09). INO 4500, a DNA Based LASV Vaccine, Induces Robust T Cell Responses and Long-Term Memory Antigen-Specific T Cells|Vaccines Conferences|International Vaccines Congress. Available online: https:\/\/vaccinescongress.com\/program\/scientific-program\/2021\/ino-4500-a-dna-based-lasv-vaccine-induces-robust-t-cell-responses-and-long-term-memory-antigen-specific-t-cells."},{"key":"ref_154","unstructured":"INOVIO Pharmaceuticals, Inc. (2024, August 09). INOVIO Provides an Update on Lassa Fever and MERS Programs. Available online: https:\/\/ir.inovio.com\/news-releases\/news-releases-details\/2022\/INOVIO-Provides-an-Update-on-Lassa-Fever-and-MERS-Programs\/default.aspx."},{"key":"ref_155","unstructured":"Baden, M., Kieh, L., Fitz-Patrick, D., Diemert, D., and Mutua, G. (2024, July 21). First Safety & Immunogenicity Data from a FIH, Placebo-Controlled, Dose-Escalation Trial of a Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine in Healthy Adults. Available online: https:\/\/www.iavi.org\/wp-content\/uploads\/2023\/11\/C102_ASTMH_Poster_Chicago2023.pdf."},{"key":"ref_156","unstructured":"Abiola, A. (2024, July 21). Time to Hope for a Lassa Fever Vaccine? GAVI, the Vaccine Alliance. Available online: https:\/\/www.gavi.org\/vaccineswork\/time-hope-lassa-fever-vaccine."},{"key":"ref_157","unstructured":"Pan African Clinical Trials Registry (2024, July 21). A Phase 1 Randomized, Blinded, Placebo Controlled, Dose-Escalation and Dosing Regimen Selection Study to Evaluate the Safety and Immunogenicity of rVSV-Vectored Lassa Virus Vaccine in Healthy Adults at Multiple Sites in West Africa. Pan African Clinical Trials Registry. Available online: https:\/\/pactr.samrc.ac.za\/TrialDisplay.aspx?TrialID=14618."},{"key":"ref_158","first-page":"1","article-title":"Management of COVID-19 vaccines cold chain logistics: A scoping review","volume":"15","author":"Fahrni","year":"2022","journal-title":"J. Pharm. Policy Pr."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2471\/BLT.08.054726","article-title":"Understandings of immunization: Some west African perspectives","volume":"86","author":"Leach","year":"2008","journal-title":"Bull World Health Organ."},{"key":"ref_160","first-page":"153","article-title":"Vaccine Hesitancy in Nigeria: Overcoming Cultural, Linguistic and Religious Obstacles","volume":"15","author":"Agbede","year":"2024","journal-title":"Inf. Impact J. Inf. Knowl. Manag."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1093\/infdis\/jiu436","article-title":"An Assessment of the Reasons for Oral Poliovirus Vaccine Refusals in Northern Nigeria","volume":"210","author":"Michael","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_162","unstructured":"World Health Organisation (2024, May 03). Report of the SAGE Working Group on Vaccine Hesitancy. Available online: https:\/\/www.asset-scienceinsociety.eu\/sites\/default\/files\/sage_working_group_revised_report_vaccine_hesitancy.pdf."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nature06536","article-title":"Global trends in emerging infectious diseases","volume":"451","author":"Jones","year":"2008","journal-title":"Nature"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid1601.081467","article-title":"Public Health Threat of New, Reemerging, and Neglected Zoonoses in the Industrialized World","volume":"16","author":"Cutler","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"ref_165","first-page":"69","article-title":"Emerging and re-emerging animal viruses","volume":"41","author":"Pepin","year":"2010","journal-title":"Foreword. Vet. Res."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"El Amri, H., Boukharta, M., Zakham, F., and Ennaji, M.M. (2020). Emergence and Reemergence of Viral Zoonotic Diseases: Concepts and Factors of Emerging and Reemerging Globalization of Health Threats. Emerging and Reemerging Viral Pathogens, Academic Press.","DOI":"10.1016\/B978-0-12-819400-3.00027-2"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","article-title":"Infectious disease in an era of global change","volume":"20","author":"Baker","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"145","DOI":"10.20506\/rst.38.1.2949","article-title":"Importance of a One Health approach in advancing global health security and the Sustainable Development Goals","volume":"38","author":"Sinclair","year":"2019","journal-title":"Rev. Sci. Tech. l\u2019OIE"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Cunningham, A.A., Scoones, I., and Wood, J.L.N. (2017). One Health for a changing world: New perspectives from Africa. Philos. Trans. R. Soc. B Biol. Sci., 372.","DOI":"10.1098\/rstb.2016.0162"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Abubakar, I.R. (2017). Access to Sanitation Facilities among Nigerian Households: Determinants and Sustainability Implications. Sustainability, 9.","DOI":"10.3390\/su9040547"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Yaya, S., Hudani, A., Udenigwe, O., Shah, V., Ekholuenetale, M., and Bishwajit, G. (2018). Improving Water, Sanitation and Hygiene Practices, and Housing Quality to Prevent Diarrhea among Under-Five Children in Nigeria. Trop. Med. Infect. Dis., 3.","DOI":"10.3390\/tropicalmed3020041"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"116","DOI":"10.11604\/pamj.2023.45.116.36979","article-title":"Fraud within the Nigerian health system, a double threat for resilience of a health system and the response to the COVID-19 pandemic: A review","volume":"45","author":"Akokuwebe","year":"2023","journal-title":"Pan Afr. Med J."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s10461-019-02538-0","article-title":"Research Capacity Strengthening in Sub-Saharan Africa: Recognizing the Importance of Local Partnerships in Designing and Disseminating HIV Implementation Science to Reach the 90\u201390\u201390 Goals","volume":"23","author":"Kalbarczyk","year":"2019","journal-title":"AIDS Behav."}],"container-title":["Tropical Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2414-6366\/9\/8\/178\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:36:16Z","timestamp":1760110576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2414-6366\/9\/8\/178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":173,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["tropicalmed9080178"],"URL":"https:\/\/doi.org\/10.3390\/tropicalmed9080178","relation":{},"ISSN":["2414-6366"],"issn-type":[{"value":"2414-6366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]}}}